Cargando…
Expression of neuro-oncological ventral antigen-1 in small-cell lung cancer and its value in pathological diagnosis
BACKGROUND: To investigate the expression of neuro-oncological ventral antigen-1 (Nova1) in small-cell lung cancer (SCLC) and its value in clinical pathological diagnosis of SCLCs. METHODS: Nova1 expression in the SCLC cell line H446, lung adenocarcinoma cell line A549, squamous cell carcinoma (SCC)...
Autores principales: | Deng, Shuangshuang, Liu, Meixuan, Xiao, Tianyu, Gao, Jinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799250/ https://www.ncbi.nlm.nih.gov/pubmed/35117458 http://dx.doi.org/10.21037/tcr.2019.12.99 |
Ejemplares similares
-
NOVA1 expression is associated with clinicopathological characteristics and prognosis in patients with small cell lung cancer
por: Liu, Meixuan, et al.
Publicado: (2020) -
High Expression of Neuro-Oncological Ventral Antigen 1 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Zhang, Yi-An, et al.
Publicado: (2014) -
MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1
por: Li, Dongyun, et al.
Publicado: (2022) -
Upregulated Neuro-oncological Ventral Antigen 1 (NOVA1) Expression Is Specific to Mature and Immature T- and NK-Cell Lymphomas
por: Kim, Eun Kyung, et al.
Publicado: (2016) -
Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function
por: Kremer, Veerle, et al.
Publicado: (2022)